Hedge Fund and Insider Trading News: Toscafund Management, Oaktree Capital Management, Worm Capital, BlackRock, Inc. (BLK), and More

Page 1 of 2

Fund Manager Reade Griffith Buys Stake in Mediaset Espana Amid Takeover (Reuters)
MADRID (Reuters) – Fund manager Reade Griffith bought a minority stake in Spanish broadcaster Mediaset Espana after its parent company MediaForEurope launched a public takeover offer, a filing to the Spanish stock regulator showed. Griffith, who heads Amsterdam-listed investment fund Tetragon’s Investment Committee, owns a 1.022% stake in Mediaset Espana through financial instruments since Monday, the regulator said on its website.

Hedge Fund Manager Quits USD22m Job to Run for US Senate (Hedge Week)
Hedge fund manager Dave McCormick quit a job that earned him more than $22 million last year to run for the US Senate in Pennsylvania, according to a a report by Federal News Network. The report cites a public financial disclosure document as the source of the information on McCormick’s earnings as CEO of the world’s largest hedge fund Bridgwater Associates.

Tosca’s Ukraine Play (Institutional Investor)
The London-based Tiger Cub is launching a new fund heavily weighted with European bank stocks. One of the longer-tenured but lesser known Tiger Cubs is raising money for a new hedge fund designed, in part, to take advantage of the selloff in European banks in the wake of Russia’s invasion of Ukraine.London-based Toscafund Management, founded by Martin Hughes, is aiming to raise more than $100…

Photo by Joshua Mayo on Unsplash

Why This Analyst Thinks Tesla’s Growth Can ‘Shock Wall Street’ For Several Years (Business Insider)
Tesla Inc. (NASDAQ:TSLA) stock is the best bet for long-term-focused investors, according to an analyst at hedge fund Worm Capital. Tesla Investors In For Superlative Returns: Tesla will likely grow production at least by 50%, on average, through 2030 as opposed to the less than 20% annualized Wall Street forecasts now, Eric Markowitz, Director of Research and Partner at Worm said.

Oaktree, Qatar Investment Inject $260M In BioXcel To Fund Commercialization Of Schizophrenia Med (Benzinga)
BioXcel Therapeutics Inc (BTAI) received strategic financing from Oaktree Capital Management and Qatar Investment Authority (QIA) for gross funding of $260 million. The Company will use the funding to support the commercial activities of Igalmi (dexmedetomidine) sublingual film indicated for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.

Page 1 of 2